Patents by Inventor Timothy J. Maziasz

Timothy J. Maziasz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160310505
    Abstract: Prostamides such as bimatoprost and its pro-drugs for enhancement of leptin production and appetite suppression.
    Type: Application
    Filed: November 25, 2015
    Publication date: October 27, 2016
    Inventors: Neil J. Poloso, David F. Woodward, Timothy J. Maziasz, Suzanne Kanaly, Grantley Charles, Michael Garst, Robert M. Burk
  • Publication number: 20140275272
    Abstract: Prostamides such as bimatoprost and its pro-drugs for enhancement of leptin production and appetite suppression.
    Type: Application
    Filed: March 13, 2014
    Publication date: September 18, 2014
    Applicant: ALLERGAN, INC.
    Inventors: Neil J. POLOSO, David F. WOODWARD, Timothy J. MAZIASZ, Suzanne KANALY, Grantley CHARLES, Michael GARST, Robert M. BURK
  • Publication number: 20040034083
    Abstract: A method of treating, preventing, or inhibiting PD, in a subject in need of such treatment, inhibition or prevention. The method comprises treating the subject with one or more cyclooxygenase-2 selective inhibitor(s) or isomer(s) or pharmaceutically acceptable salt(s), ester(s), or prodrug(s) thereof, in combination with one or more second drugs, wherein the amount of the cyclooxygenase-2 selective inhibitor(s) or isomer(s) or pharmaceutically acceptable salt(s), ester(s), or prodrug(s) thereof in combination with the amount of second drug(s) constitutes a PD treatment, inhibition or prevention effective amount.
    Type: Application
    Filed: April 14, 2003
    Publication date: February 19, 2004
    Inventors: Diane T. Stephenson, Peter C. Isakson, Timothy J. Maziasz
  • Publication number: 20040006100
    Abstract: A method of treating, preventing, or inhibiting PD, in a subject in need of such treatment, inhibition or prevention. The method comprises treating the subject with one or more cyclooxygenase-2 selective inhibitor(s), ester(s), salt(s) or prodrug(s) thereof, wherein the amount of the cyclooxygenase-2 selective inhibitor(s), ester(s), salt(s) or prodrug(s) thereof constitutes a PD treatment, inhibition or prevention effective amount of the COX 2 inhibitor(s).
    Type: Application
    Filed: April 14, 2003
    Publication date: January 8, 2004
    Inventors: Diane T. Stephenson, Peter C. Isakson, Timothy J. Maziasz